News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Enteris Biopharma Emerges From the Ashes of Unigene Laboratories, Inc. (UGNE), Hunts for Deals


8/28/2013 7:08:35 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

What’s in a new name? More than usual for Enteris Biopharma. That’s because the Boonton, NJ-based biotech is what remains of Unigene Laboratories, a three-decade old company best known both for a way to turn injectable peptide drugs into pills, and disappointing Wall Street investors. Unigene is now in the biotech graveyard, having been vanquished by debt and crippling regulatory decisions, and ultimately sold in pieces at a few auctions earlier this year.

Help employers find you! Check out all the jobs and post your resume.

Read at Xconomy

comments powered by Disqus
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES